ClinicalTrials.gg
RecruitingNCT07435818MCT-EDUpdated Mar 13, 2026

Feasibility and Acceptability of Metacognitive Training for Eating Disorders in Adolescents With Anorexia Nervosa

An interventional study of Metacognitive Training for Eating Disorders in Anorexia Nervosa and Atypical Anorexia Nervosa, sponsored by University of Évora. Recruiting at 1 site in Portugal. Open to participants aged 13 Years to 19 Years. Per ClinicalTrials.gov, last updated 2026-03-13.

Sponsored by University of Évora · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
13 Years to 19 Years
Sex
All
01

Study summary

This study aims to assess the feasibility and acceptability of Metacognitive Training for Eating Disorders (MCT-ED) in adolescents with anorexia nervosa and atypical anorexia nervosa.

Read the detailed description

Anorexia nervosa is the eating disorder associated with the highest mortality rate, with peak incidence occurring during adolescence. Recent studies indicate that, globally, the incidence of adolescent anorexia nervosa has increased by approximately 17% over the past 30 years, with a further rise observed during and following the COVID-19 pandemic. The consequences of untreated anorexia nervosa extend into adulthood, significantly affecting both physical and mental health, resulting in long-term morbidity and a substantial burden on society. Elevated levels of perfectionism and cognitive inflexibility are commonly observed in this population and are thought to contribute to the maintenance of eating disorder symptoms as well as resistance to treatment. Accordingly, the MCT-ED aims to reduce rigid and inflexible thinking styles, decrease perfectionism, and address cognitive biases that perpetuate the symptoms of the disorder.

The primary aim of this feasibility study is to assess key process indicators, including recruitment, retention, adherence to the intervention, and safety. To ensure reproducibility, a session checklist will be used to document both intervention delivery and participant engagement for each session. A minimum fidelity plan will include routine supervision of intervention delivery by a senior team researcher with expertise in metacognitive training, optionally supported by an additional research team member with experience in eating disorders and adolescent populations.

Potential participants are referred to the study by the treatment clinical team (child and adolescent psychiatrist/psychiatrist) during eating disorder consultations, only after the adolescent and/or their parent/guardian have provided explicit consent for their contact details to be shared with the research team. For recruitment purposes, a member of the research team contacts potential participants by telephone to schedule an initial videoconference meeting with the adolescent and their legal guardians.

All participants will be invited to take part in an optional brief interview at the end of the intervention and completion of all study assessments. Interviews are conducted via videoconference by a member of the research team who is independent from the therapist who delivered the intervention. The semi-structured interview explores participants' perceptions of the intervention, including overall evaluation, perceived benefits, most and least useful components, age-appropriateness, comprehension, session format and structure, exercises and workbooks, study questionnaires, potential involvement of caregivers, and suggestions for improvement. This approach allows systematic collection of feedback on acceptability, practicality, and potential areas for refinement. Participants who choose not to participate will still have their study participation preserved, including attendance at intervention sessions and completion of study questionnaires.

For CONSORT reporting purposes, the number of participants allocated to the intervention, those who received the intervention, and those who did not receive the intervention, together with reasons, will be documented. In addition, losses to follow-up and discontinuation of the intervention, including reasons where possible, will be recorded. Finally, the number of participants invited to take part in the qualitative interview and the number who completed the interview will be documented.

Progression decisions in this feasibility and acceptability study are guided by predefined criteria using a three-tiered traffic-light system to support interpretation and decision-making.

02

Conditions studied

  • Anorexia Nervosa
  • Atypical Anorexia Nervosa

Keywords

  • Feasibility Studies
  • adolescent
  • anorexia nervosa
  • metacognitive training
  • feeding and eating disorders
03

In context

Anorexia Nervosa

469 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.

This study's planned enrollment of 14 is below the median of 46 across 313 interventional studies indexed under Anorexia Nervosa.

Browse Anorexia Nervosa studies →

Lead sponsor

University of Évora is the lead sponsor of 34 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adolescents aged 13 to 19 years;
  • Diagnosis of Anorexia Nervosa or Atypical Anorexia Nervosa; confirmed by the treating child and adolescent psychiatrist according to or ICD-11 criteria;
  • Currently followed in an Eating Disorder Outpatient Consultation;
  • Fluent in Portuguese.

Exclusion criteria

Exclusion Criteria:

  • Acute suicidal ideation or behaviour requiring immediate clinical intervention;
  • Imminent risk of hospitalization due to clinical deterioration;
  • Current diagnosis of psychotic disorder, bipolar disorder, or substance dependence;
  • Any clinical condition that, in the judgment of the treating clinician, would make participation in a videoconference-based intervention inappropriate.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (estimated)

Study arms

  • Experimental
    Metacognitive Training for Eating Disorders + Treatment as usual (TAU)

    Adolescents with Anorexia Nervosa ou Atypical Anorexia Nervosa. The adolescent continues to receive any ongoing standard care (treatment as usual, TAU)

    Behavioral: Metacognitive Training for Eating Disorders

Interventions

  • BehavioralMetacognitive Training for Eating Disorders

    The intervention consists of six modules delivered across six synchronous sessions, each lasting up to 50 minutes, over a six-week period, and conducted by a mental health specialist nurse. The intervention includes one thinking styles module, two cognitive flexibility modules, two perfectionism modules, and one concluding summary module. At the beginning of each session, exercises completed at home between sessions are reviewed. All sessions are conducted individually via a video-conferencing platform, with materials presented using Microsoft PowerPoint®. Each module incorporates psychoeducational content, interactive exercises, videos, and guided reflection activities.

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    Proportion of eligible participants who consent to participate in the study, calculated as the number recruited divided by the number eligible and approached Minimum Progression Criterion: ≥ 50% of eligible participants consent to participate

    Time frame: Through study completion, an average of 1 year

  2. Retention/Completion rate

    Proportion of participants who completed the full intervention and all planned outcome assessments Minimum Progression Criterion: ≥ 70% of participants complete the intervention and assessments

    Time frame: Through study completion, an average of 1 year

  3. Intervention engagement / adherence

    Number of synchronous sessions attended (out of six), which determines exposure to the six intervention modules, and level of engagement during sessions. Engagement with recommended between-session exercises, which are not mandatory, will also be recorded as an indicator of optional participation rather than required adherence Minimum Progression Criterion: ≥83% of participants attend at least 5 of the 6 synchronous sessions and demonstrate adequate in-session engagement, defined as participation in at least one core exercise per attended session. Engagement with recommended workbook exercises related to the core modules (cognitive flexibility and perfectionism) will be recorded descriptively through therapist review of the workbook and will not constitute a mandatory criterion for progression.

    Time frame: Through study completion, an average of 1 year

  4. Safety and adverse events

    Adverse events are defined as any unexpected or clinically significant occurrences potentially related to the intervention, including: * Clinical deterioration: marked increase in core AN symptoms (e.g., restrictive eating, purging, excessive exercise) compared to baseline; * Suicidal ideation or self-harm: thoughts, plans, or behaviours indicating risk of self-injury; * Need for urgent medical intervention: emergency visits, hospitalization, or other urgent care; * Other unexpected adverse events potentially linked to the study participation. Intervention suspension criteria: * Severe clinical deterioration in AN symptoms * Emergence of suicidal ideation or self-harm behaviours Mild or moderate adverse events do not automatically lead to suspension but are monitored and managed in coordination with the treating clinician. Minimum Progression Criterion: No severe adverse events attributable to the intervention.

    Time frame: Through study completion, an average of 1 year

  5. Participant evaluation

    A 16-item questionnaire is administered to participants upon completion of the intervention and all post-intervention assessments. The questionnaire is designed to assess participant satisfaction and the acceptability of the Metacognitive Training for Eating Disorders (MCT-ED). Items 1-14: Rated on a 5-point Likert scale ranging from 1 ("strongly disagree") to 5 ("strongly agree"). These items assess key aspects of participants' experience, including: Usefulness and applicability of the content in daily life; Motivation and engagement with the sessions; Understanding of objectives and content; Satisfaction with session format and accessibility (online, individual, and appropriate sessions and intervention duration); Overall satisfaction and intention to recommend the intervention. Items 15-16: Open-ended questions collecting qualitative feedback.

    Time frame: During week 7 following intervention initiation

  6. Semi-structured interviews

    All participants who have completed the intervention and the study assessments are offered the opportunity to take part in an optional interview at the end of the study. All participants who agree to take part are interviewed. Interviews are conducted via videoconference by a member of the research team who is independent from the therapist delivering the intervention. The interview explores participants' perceptions of the intervention, including their overall evaluation, the components they found most and least useful, age-appropriateness and comprehension, suggestions for improvement, the structure and dose of sessions, the format (individual, online, videoconference), the workbooks and exercises, the study questionnaires, the potential involvement of caregivers, and any final reflections or additional comments. This approach ensures systematic collection of feedback on acceptability, perceived benefits, practicality, and potential improvements.

    Time frame: During week 8 following intervention initiation

Secondary outcomes

  1. ED behaviours and attitudes: Eating Disorder Examination Questionnaire -(EDE-Q) (Fairburn & Beglin, 1994); Portuguese validated version EDE-Q 5.2. (Machado et al., 2014)

    The EDE-Q is a self-report instrument consisting of 28 items across four subscales: Restraint, Eating Concern, Shape Concern, and Weight Concern. Items are rated on a 7-point Likert scale (0-6), with higher scores indicating greater concern with eating, weight, and body shape and/or more maladaptive eating-related behaviours. The questionnaire assesses both cognitive-attitudinal features and the frequency of key disordered eating behaviours over a 28-day reference period. A higher global score reflects greater overall severity of eating disorder symptoms. To obtain a subscale score, the ratings for the relevant items are added together and the sum divided by the total number of items forming the subscale. To obtain an overall or 'global' score, the four subscales' scores are summed and the resulting total divided by the number of subscales (i.e. four).

    Time frame: Baseline (up to one week before the intervention) and Immediately after the intervention (up to one week after the end of the intervention)

  2. Perfectionism: Frost Multidimensional Perfectionism Scale (FMPS) (Frost et al., 1990). The Portuguese version of the FMPS validated by Carmo et al. (2017)

    The Organization subscale consists of six items. Each item is rated on a 5-point Likert scale (1 = strongly disagree, 5 = strongly agree). The total FMPS score was calculated by summing five subscales (Personal Standards, Concern over Mistakes, Doubts about Actions, Parental Expectations, and Parental Criticism), excluding the Organization subscale due to its weaker correlations with the other dimensions. The Organization subscale is reported separately. All items are scored in the same direction, with higher scores indicating greater levels of perfectionism in each domain. Elevated scores reflect stronger perfectionistic tendencies, including heightened concern about mistakes, higher personal standards, perceived parental pressure, doubts about performance, and preference for organization.

    Time frame: Baseline (up to one week before the intervention) and Immediately after the intervention (up to one week after the end of the intervention)

  3. Cognitive Flexibility/Body Image Flexibility: Body Image Acceptance and Action Questionnaire (BI-AAQ) (Sandoz et al., 2013); Portuguese validated version: Ferreira, C., Pinto-Gouveia, J., & Duarte, C. (2011)

    The BI-AAQ is a self-report instrument consisting of 12 items that measure body image-related psychological flexibility, including body image acceptance and experiential avoidance. Each item is rated on a 7-point Likert scale (1 = never true, 7 = always true). All items are reverse-scored so that higher scores reflect greater body image-related psychological flexibility and acceptance, whereas lower scores indicate higher inflexibility and experiential avoidance. The total score is calculated as the sum of all 12 items, resulting in a possible range of 12 to 84.

    Time frame: Baseline (up to one week before the intervention) and Immediately after the intervention (up to one week after the end of the intervention)

07

Study locations

1 of 1 sites recruiting
  • Hospital Beatriz Ângelo - Unidade Local de Saúde Loures-Odivelas, Child and Adolescent Psychiatry Service, Department of Psychiatry and Mental Health, Loures, Portugal
    Loures, Portugal
    Recruiting
    • Andreia Espírito Santo, PhD Student · Contactacj.santo@ensp.unl.pt · 00351 21 984 7200
    • Lara Pinho, PhD · Contactl.pinho@ess.ipvc.pt
    • Andreia Espírito Santo, PhD Student · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Mar 2027, 12 months after the start.

Of 151 non-industry interventional studies with no phase under Anorexia Nervosa, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 63. This study's planned 12 months is below that.

Counting every sponsor, half of 151 studies reached it within 43 months; a quarter within 24 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 15, 2026
First posted
Feb 27, 2026
StartActual
Mar 2, 2026
Primary completionEst.
Mar 2027
CompletionEst.
Jun 2027
Last update
Mar 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07435818
Lead sponsor
University of Évora
Collaborators
Fundação para a Ciência e a Tecnologia, Universidade Nova de Lisboa, Comprehensive Health Research Center
Responsible party
Andreia Cristina Jales do Espírito Santo (PhD Student, Principal Investigator, University of Évora) — Principal investigator
First posted
Feb 27, 2026
Start date
Mar 2, 2026
Primary completion
Mar 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Mar 13, 2026

Study contacts

Andreia Espírito Santo, PhD Student
Contact
acj.santo@ensp.unl.pt
00351219 847 200
Lara Pinho, PhD
Contact
l.pinho@ess.ipvc.pt
Lara Pinho, PhD
study chair · Universidade de Évora, Comprehensive Health Research Centre (CHRC) LA-REAL, Évora, Portugal
Francisco Sampaio
study chair · Nursing School of the University of Porto, Porto, Portugal
Andreia Espírito Santo, PhD Student
principal investigator · NOVA National School of Public Health, Comprehensive Health Research Centre, REAL, CCAL, Portugal

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion